ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to unleash immune system on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new medicine, TAK-188, designed to help the immune system fight advanced solid tumors that haven't responded to standard treatments. TAK-188 targets and removes certain cells inside tumors that weaken the immune response, potentially allowing cancer-fighting ce…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called BH3120, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shrinks tumors. About 245 adults…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IDE161, alone or with another drug (pembrolizumab), in people with advanced solid tumors (like breast, ovarian, prostate, or lung cancer). The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. Ab…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New cancer drug KK2260 enters first human trials
Disease control Recruiting nowThis study is the first time the experimental drug KK2260 is being tested in people. It aims to find a safe dose and check for side effects in about 189 adults with advanced or metastatic solid tumors (cancers that have spread). The trial includes people with esophageal or head a…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC